Martin H.. Huber Jr's Net Worth

$2.42 Million

Estimate Recalculated Apr 3, 2024 07:17PM EST

Who is Martin H.. Huber Jr?

Martin H.. Huber Jr has an estimated net worth of $2.42 Million. This is based on reported shares across multiple companies, which include Mersana Therapeutics, Inc., Syndax Pharmaceuticals Inc, Xilio Therapeutics, Inc., and TESARO, Inc..

SEC CIK

Martin H.. Huber Jr's CIK is 0001653276

Past Insider Trading and Trends

2023 was Martin H.. Huber Jr's most active year for acquiring shares with 10 total transactions. Martin H.. Huber Jr's most active month to acquire stocks was the month of February. 2017 was Martin H.. Huber Jr's most active year for disposing of shares, totalling 9 transactions. Martin H.. Huber Jr's most active month to dispose stocks was the month of December. 2021 saw Martin H.. Huber Jr paying a total of $677,600.00 for 219,598 shares, this is the most they've acquired in one year. In 2019 Martin H.. Huber Jr cashed out on 210,104 shares for a total of $915,450.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mersana Therapeutics, Inc. (MRSN) Snapshot price: $3.54

President, CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Oct 2
Form 4
—
0
—
—
0
Sep 11
Form 4
—
0
—
—
0
Jul 3
Form 4
∞
14.47K
—
—
14.47K
Jun 8
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Apr 13
Form 3
—
0
—
—
0
No matching records found

Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+53.13%
17K
—
—
49K
Feb 7
Form 4
+100.00%
16K
—
—
32K
Feb 2
Form 4
∞
16K
—
—
16K
Feb 2
Form 4
—
0
—
—
0
Sep 15
Form 3
—
0
—
—
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.6455

PRESIDENT AND HEAD OF R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 16
Form 4
—
0
—
—
0
Jan 1
Form 4/A
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Oct 21
Form 3
—
0
—
—
0
No matching records found

TESARO, Inc. No price found

SVP & Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-12.21K
$75.00
-$915,450.00
0
Jan 22
Form 4
+7.76%
879
$37.63
-$13,960.73
12.21K
Scheduled
Sep 21 - Sep 24
Form 4
+55.76%
4.05K
$54.86
-$98,912.58
11.33K
Scheduled
Mar 1 - Mar 2
Form 4
+14.50%
921
$85.24
-$70,663.96
7.27K
Dec 1 - Dec 4
Form 4
—
0
—
—
0
Nov 16
Form 4
+11.56%
658
$118.60
-$70,211.20
6.35K
Scheduled
Sep 21 - Sep 22
Form 4
+19.30%
921
$153.02
-$126,853.58
5.69K
Apr 1 - Apr 3
Form 4
—
0
—
—
0
Mar 27
Form 4
+161.48%
2.95K
$177.61
-$253,627.08
4.77K
Scheduled
Mar 1 - Mar 2
Form 4
∞
310
$136.26
-$25,889.40
13.39
Jan 1 - Jan 3
Form 4
+79.93%
673
$121.29
-$39,661.83
1.51K
Nov 1 - Nov 2
Form 4
∞
842
$108.12
-$44,112.96
842
Scheduled
Sep 21 - Sep 22
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Sep 21
Form 3
—
0
—
—
0
No matching records found